Jaguar Health (JAGX) Raw Materials (2018 - 2026)

Jaguar Health (JAGX) has 9 years of Raw Materials data on file, last reported at $4.9 million in Q1 2026.

• On a quarterly basis, Raw Materials rose 160.82% year-over-year to $4.9 million in Q1 2026; TTM through Mar 2026 was $4.9 million, a 160.82% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 10.32% from the prior year.
• Raw Materials for Q1 2026 stood at $4.9 million, up from $2.0 million in the prior quarter.
• Over the last five years, Raw Materials for JAGX reached as high as $4.9 million in Q1 2026 and fell as low as $1.6 million in Q1 2022.
• Historically, Raw Materials has averaged $2.1 million across 5 years, with a median of $2.0 million in 2025.
• Across the five-year window, Raw Materials jumped 178.46% in 2022 and retreated 14.58% in 2025, its largest moves.
• Year by year, Raw Materials stood at $2.1 million in 2022, then declined by 2.09% to $2.1 million in 2023, then dropped by 10.06% to $1.8 million in 2024, then grew by 10.32% to $2.0 million in 2025, then surged by 140.37% to $4.9 million in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $4.9 million in Q1 2026, $2.0 million in Q4 2025, and $2.0 million in Q3 2025.